Eclosion Emerges to Fill A Swiss Start-Up Void

Despite being home to renowned research institutions and universities and mid- to large-size biopharma companies, Geneva, Switzerland, midway through the last decade, still lacked what it considered a vibrant life sciences start-up scene. A few years later and the Swiss region’s all-hands-on deck approach to building one has birthed a new hybrid model, the public/private endeavor Eclosion, which is one part early-stage incubator and another part venture fund.